Skip to main content
Signal8

Simon Willy Jules

SEC insider (Form 3/4/5 filer). CIK 0001325410. Director at OKYO Pharma Ltd (OKYO). 1 reported Form 4/5 transaction since Sep 2024; latest on Jun 8, 2026. Located in LONDON.

Companies Simon Willy Jules has filed insider reports for

  • OKYO Pharma Ltd (OKYO): Director
Simon Willy Jules profile photo

Simon Willy Jules

CIK: 0001325410

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OKYO Pharma Ltd logo
OKYO

OKYO Pharma Ltd

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • OKYO Pharma Ltd logo
    OKYO

    OKYO Pharma Ltd

    Jun 8, 2026
    Award

    Option

    Direct
    6.5K shares at avg. $1.85-

1-1 of 1